Table 3

Type of patients and interventions in randomised controlled trials

TotalDrugProcedureDeviceOthers
(n=252)(n=197)(n=40)(n=10)(n=5)
Ischaemic heart disease85(33.7)70(35.5)8(20.0)7(70.0)0(0.0)
Hypertension34(13.5)30(15.2)3(7.5)0(0.0)1(20.0)
Heart failure32(12.7)23(11.7)8(20.0)0(0.0)1(20.0)
Dyslipidaemia25(9.9)24(12.2)0(0.0)0(0.0)1(20.0)
Atrial fibrillation16(6.3)11(5.6)5(12.5)0(0.0)0(0.0)
Cardiac surgery10(4.0)4(2.0)6(15.0)0(0.0)0(0.0)
Chronic kidney disease9(3.6)7(3.6)1(2.5)0(0.0)1(20.0)
Healthy volunteer8(3.2)6(3.0)1(2.5)1(10.0)0(0.0)
Diabetes mellitus2(0.8)2(1.0)0(0.0)0(0.0)0(0.0)
Others31(12.3)20(10.2)8(20.0)2(20.0)1(20.0)
  • Values are expressed as numbers (percentages).